Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitta U Monz

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Pharmacoeconomics|September 9, 2010
Cost effectiveness of venous thromboembolism pharmacological prophylaxis in total hip and knee replacement: a systematic reviewJonathan M Plumb, Andreas Clemens, Brigitta U Monz
Autism Research : Official Journal of the International Society for Autism Research|January 11, 2019
Treatment patterns in children with autism in the United StatesBrigitta U Monz, Richard Houghton, Kiely Law, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 15, 2013
Major bleeding in patients with atrial fibrillation receiving vitamin K antagonists: a systematic review of randomized and observational studiesNeil S Roskell, Miny Samuel, Herbert Noack, et al.
Journal of Medical Economics|July 9, 2010
Cost effectiveness of tiotropium for chronic obstructive pulmonary disease: a systematic review of the evidenceJosephine A Mauskopf, Christine L Baker, Brigitta U Monz, et al.
BMJ Open|December 18, 2012
Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross-sectional analysis using the General Practice Research DatabaseSally Lee, Brigitta U Monz, Andreas Clemens, et al.
Applied Health Economics and Health Policy|February 5, 2024
Evidence Synthesis and Linkage for Modelling the Cost-Effectiveness of Diagnostic Tests: Preliminary Good Practice RecommendationsBethany Shinkins, A Joy Allen, James Karichu, et al.
Treatments in Respiratory Medicine|February 24, 2005
Development and validation of a patient satisfaction and preference questionnaire for inhalation devicesChris M Kozma, Terra L Slaton, Brigitta U Monz, et al.
Pharmacoeconomics|April 26, 2013
A comparative analysis of models used to evaluate the cost-effectiveness of dabigatran versus warfarin for the prevention of stroke in atrial fibrillationSonja V Sorensen, Siyang Peng, Brigitta U Monz, et al.
Respiratory Medicine|November 18, 2009
Responsiveness of the cough and sputum assessment questionnaire in exacerbations of COPD and chronic bronchitisBrigitta U Monz, Paul Sachs, Jeffrey McDonald, et al.
Obstetrics and Gynecology|November 4, 2008
Sexual problems and distress in United States women: prevalence and correlatesJan L Shifren, Brigitta U Monz, Patricia A Russo, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Pharmacoeconomics|September 9, 2010
Cost effectiveness of venous thromboembolism pharmacological prophylaxis in total hip and knee replacement: a systematic reviewJonathan M Plumb, Andreas Clemens, Brigitta U Monz
Autism Research : Official Journal of the International Society for Autism Research|January 11, 2019
Treatment patterns in children with autism in the United StatesBrigitta U Monz, Richard Houghton, Kiely Law, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 15, 2013
Major bleeding in patients with atrial fibrillation receiving vitamin K antagonists: a systematic review of randomized and observational studiesNeil S Roskell, Miny Samuel, Herbert Noack, et al.
Journal of Medical Economics|July 9, 2010
Cost effectiveness of tiotropium for chronic obstructive pulmonary disease: a systematic review of the evidenceJosephine A Mauskopf, Christine L Baker, Brigitta U Monz, et al.
BMJ Open|December 18, 2012
Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross-sectional analysis using the General Practice Research DatabaseSally Lee, Brigitta U Monz, Andreas Clemens, et al.
Applied Health Economics and Health Policy|February 5, 2024
Evidence Synthesis and Linkage for Modelling the Cost-Effectiveness of Diagnostic Tests: Preliminary Good Practice RecommendationsBethany Shinkins, A Joy Allen, James Karichu, et al.
Treatments in Respiratory Medicine|February 24, 2005
Development and validation of a patient satisfaction and preference questionnaire for inhalation devicesChris M Kozma, Terra L Slaton, Brigitta U Monz, et al.
Pharmacoeconomics|April 26, 2013
A comparative analysis of models used to evaluate the cost-effectiveness of dabigatran versus warfarin for the prevention of stroke in atrial fibrillationSonja V Sorensen, Siyang Peng, Brigitta U Monz, et al.
Respiratory Medicine|November 18, 2009
Responsiveness of the cough and sputum assessment questionnaire in exacerbations of COPD and chronic bronchitisBrigitta U Monz, Paul Sachs, Jeffrey McDonald, et al.
Obstetrics and Gynecology|November 4, 2008
Sexual problems and distress in United States women: prevalence and correlatesJan L Shifren, Brigitta U Monz, Patricia A Russo, et al.
Pageof 3